>
The WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program has expanded its ability to offer chimeric antigen receptor T-cell (CAR-T) therapy to patients with relapsed or ref [...]
Anne Schnatterly, M.B.A, B.S.N., R.N., C.C.R.P., WVU Cancer Institute Clinical Research Unit director, was selected to join the American Association of Cancer Institutes (AACI) Clinical Research Innov [...]
The Comprehensive Breast Care Program at the WVU Cancer Institute has again been granted a full three-year accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a [...]

JOIN OUR TEAM

 

© 2021 Copyright - West Virginia University Health System.